US Bancorp DE Trims Stock Holdings in Doximity, Inc. $DOCS

US Bancorp DE decreased its position in Doximity, Inc. (NASDAQ:DOCS) by 15.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,260 shares of the company’s stock after selling 1,919 shares during the period. US Bancorp DE’s holdings in Doximity were worth $629,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its stake in Doximity by 8.8% in the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock worth $707,646,000 after acquiring an additional 990,923 shares during the last quarter. Invesco Ltd. raised its stake in Doximity by 54.8% in the 1st quarter. Invesco Ltd. now owns 1,969,326 shares of the company’s stock worth $114,280,000 after acquiring an additional 696,923 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Doximity by 130.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock worth $114,133,000 after acquiring an additional 1,113,076 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in Doximity by 9.5% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,730,282 shares of the company’s stock worth $100,408,000 after acquiring an additional 150,574 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its stake in shares of Doximity by 8.2% during the 1st quarter. Bank of New York Mellon Corp now owns 1,137,912 shares of the company’s stock valued at $66,033,000 after buying an additional 86,135 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on DOCS. Piper Sandler lifted their price objective on Doximity from $65.00 to $69.00 and gave the company an “overweight” rating in a research note on Monday, August 11th. Needham & Company LLC lifted their price objective on Doximity from $67.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, August 8th. Zacks Research lowered Doximity from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Wells Fargo & Company lifted their price objective on Doximity from $55.00 to $62.00 and gave the company an “equal weight” rating in a research note on Monday, August 4th. Finally, Bank of America lifted their price objective on Doximity from $55.00 to $62.00 and gave the company a “neutral” rating in a research note on Wednesday, June 25th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $69.37.

Insider Transactions at Doximity

In other news, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the transaction, the director directly owned 16,618 shares in the company, valued at $948,721.62. The trade was a 10.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the transaction, the director owned 3,221 shares in the company, valued at approximately $241,575. This represents a 86.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 37,000 shares of company stock worth $2,635,880 in the last ninety days. Insiders own 31.30% of the company’s stock.

Doximity Trading Up 0.3%

NASDAQ:DOCS opened at $67.56 on Monday. Doximity, Inc. has a 12 month low of $40.87 and a 12 month high of $85.21. The stock has a 50 day moving average of $69.22 and a two-hundred day moving average of $61.32. The firm has a market cap of $12.65 billion, a P/E ratio of 67.56, a price-to-earnings-growth ratio of 4.10 and a beta of 1.38.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter last year, the company posted $0.28 earnings per share. The company’s revenue for the quarter was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, research analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.